Calian reports 19.9% revenue growth and 35% adjusted EBITDA increase, with backlog reaching $1.40B in Q3.
Calian Group posted Q3 non-GAAP earnings per share of $0.51 as revenue climbed 19.9% year-over-year to $230.4M. The company attributed the growth to strong demand across its segments and new contract signings.
Adjusted EBITDA surged 35% to $25.57M, driving margin expansion to 11.10%. The backlog reached $1.40B, bolstered by $168.00M in new contracts and a CAD$296.00M, 15-year training agreement with the British Army.
The results reflect continued execution in defense, healthcare, and advanced technologies, positioning the company for sustained growth.